Document Detail


Calcitonin in the treatment of transient osteoporosis of the hip.
MedLine Citation:
PMID:  12833247     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Transient osteoporosis of the hip (TOH) is a rare clinical disorder of unknown etiology characterized by hip pain and functional disability that resolve spontaneously in 6-24 months. OBJECTIVES: To report 2 patients with TOH during pregnancy who had rapid resolution of their illness with the use of calcitonin. To review the literature on TOH with special emphasis on its treatment. METHODS: A MEDLINE search of studies published from 1966 to 2002 was performed to review treatment options for TOH and their effect on the natural history of the disease. RESULTS: Our 2 patients developed hip pain during pregnancy with classical changes of TOH on MRI. Both patients received calcitonin, 1 during pregnancy and 1 postpartum with resolution of their symptoms within 6 to 9 weeks. Previous reports in the literature of treatment of TOH showed that antiresorptive agents (bisphosphonates and calcitonin) had shortened the duration of the illness compared with the natural history of the disease. CONCLUSIONS: TOH is an under-recognized entity associated with pain and disability. The use of antiresorptive agents may be of help in reducing the duration of the disease. RELEVANCE: To increase the recognition of TOH and to consider therapeutic interventions to shorten the duration of the disease.
Authors:
Thurayya K Arayssi; Hussein A Tawbi; Ihab M Usta; Mukbil H Hourani
Related Documents :
17713817 - Management of biliary tract disease during pregnancy: a decision analysis.
1950237 - A retrospective study of bronchoalveolar lavage cytology in horses with clinical findin...
3811857 - Typhoid fever in pregnancy. case report and review of the literature.
20297937 - Persistence of low platelet adhesiveness in von willebrand disease during pregnancy.
24932427 - The role of endocrine disruptors in the epigenetics of reproductive disease and dysfunc...
10996687 - Obstetric and neonatal outcome of babies weighing more than 4.5 kg: an analysis by parity.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Seminars in arthritis and rheumatism     Volume:  32     ISSN:  0049-0172     ISO Abbreviation:  Semin. Arthritis Rheum.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-06-30     Completed Date:  2003-10-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1306053     Medline TA:  Semin Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  388-97     Citation Subset:  IM    
Copyright Information:
Copyright 2003 Elsevier Inc. All rights reserved.
Affiliation:
Departments of Internal Medicine, Obstetrics and Gynecology and Diagnostic Radiology, American University of Beirut, Beirut, Lebanon.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Calcitonin / therapeutic use*
Female
Hip Joint*
Humans
Osteoporosis / complications,  drug therapy*,  pathology
Pain / drug therapy*,  etiology
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Chemical
Reg. No./Substance:
9007-12-9/Calcitonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 1...
Next Document:  A comparison of various therapeutic exercises on the functional status of patients with knee osteoar...